Free press releases distribution network?

Agency / Source: Cerulean Associates, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Speed Drug Development - Cerulean's John Avellanet Joins with FDA Officials to Speak on QbD - Pharmaceutical companies face another hidden secret when struggling against a shrinking R&D pipeline and slow FDA approvals: data quality or lack thereof
Speed Drug Development - Cerulean's John Avellanet Joins with FDA Officials to Speak on QbD

 

PRZOOM - /newswire/ - Williamsburg, VA, United States, 2008/10/02 - Pharmaceutical companies face another hidden secret when struggling against a shrinking R&D pipeline and slow FDA approvals: data quality or lack thereof.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The little secret of drug development: record integrity can make or break you. Without data quality, you can expect nothing but delays from the FDA. That means wasted money, poor investment returns and increased executive liability. And that’s just one of the challenges facing the pharmaceutical industry’s shrinking pipeline.

Speakers from the U.S. Food and Drug Administration (FDA), Cerulean Associates and several other companies will look at the progress, challenges and opportunities facing the drug industry’s quest to speed drug development through Quality by Design. Mr. John Avellanet, Cerulean’s Managing Director, will speak on the challenges executives must overcome to ensure data integrity and regulatory approval.

Mr. Avellanet has won wide praise over the past year for his informative and entertaining presentations. Several attendees of last month’s Contract Pharmaceutical & Outsourcing Conference signed up for the two-day affair just to see Mr. Avellanet’s 45-minute presentation.

“I’d go out of my way to hear John speak on any subject just to enjoy his style of message delivery,” said Wayne Starnes, a CEO and recent conference attendee.

You can register for the webcast of this event at: PharmaQbD.com. Journalists needing an advanced copy of Mr. Avellanet’s presentation, or access to some of his other published work on speeding new drug development, may contact him directly.

John Avellanet is a leading expert, speaker and syndicated author on cost-effective compliance and quality systems. A former C-level executive for a Fortune 50 combination device and biotechnology subsidiary, he writes the monthly executive newsletter, SmarterCompliance™. In 2006, he co-founded his independent consulting firm, Cerulean Associates LLC.

Cerulean Associates LLC (ceruleanllc.com) is a small, private compliance consulting company that helps executives implement lean compliance, quality by design and effective management oversight, in part through its SmarterCompliance™ Toolkit executive coaching program.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Cerulean Associates, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Speed Drug Development - Cerulean's John Avellanet Joins with FDA Officials to Speak on QbD

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: John Avellanet - CeruleanLLC.com 
john[.]ceruleanllc.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Cerulean Associates, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Cerulean Associates, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  RightITnow Ltd

Visit  JobsWare.com

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today